The U.S. Supreme Court delivered a significant ruling on June 27, 2026, limiting the ability of state courts to impose liability standards on companies that have already been regulated by federal agencies. In a 7-2 decision, the Court held that state courts cannot require additional warnings on products when the Environmental Protection Agency (EPA) has determined such warnings are unnecessary.
The case centered on claims against Bayer, which acquired Monsanto, the maker of the herbicide Roundup, in 2019. A Missouri man alleged that exposure to Roundup caused his cancer and sought $1.25 million in damages, arguing the product’s label lacked a proper warning. However, the EPA has repeatedly tested Roundup and found no evidence linking it to cancer, thereby refusing to mandate a warning label.
The Supreme Court’s decision effectively halts thousands of similar lawsuits against Bayer and other companies facing claims that their products cause cancer or other harm despite federal regulatory approval. The ruling reinforces federal authority over product regulation and preempts state-level litigation that attempts to impose stricter labeling or liability requirements.
The Court’s majority contended that allowing state courts to impose divergent standards would undermine the federal regulatory framework and create inconsistent obligations for manufacturers. Justice Clarence Thomas, writing for the majority, emphasized that federal agencies’ scientific assessments and risk evaluations should be the guiding standards in such cases.
Dissenting justices expressed concern that the ruling could limit remedies available to consumers harmed by products potentially mischaracterized or insufficiently labeled. They argued that state courts should retain the ability to protect public health when federal standards may lag behind emerging science.
The ruling comes amidst ongoing debate over the role of scientific evidence in mass tort litigation, particularly in cases involving allegations of cancer caused by chemical exposures. Critics of these lawsuits argue that many are driven by trial lawyers seeking large settlements based on disputed or junk science, often funded by expert witnesses whose credibility is questioned.
By curtailing the wave of litigation based on claims unsupported by federal regulatory findings, the Supreme Court has delivered a major victory to manufacturers and industries facing extensive legal challenges. At the same time, the decision raises questions about the balance between federal oversight and state consumer protections in product liability cases.